Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.36 |
| ▸ | RELA | Q04206 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12637488 | 0.83 | HPGD (0.40) | NPC1TP53HPGDNFKB1RAB9A | |
| SCHEMBL12637491 | 0.81 | NPC1 (0.34) | NPC1TP53HPGDNFKB1RAB9A | |
| SCHEMBL12637487 | 0.79 | HTR2C (0.33) | NPC1TP53HPGDNFKB1RAB9A | |
| SCHEMBL12637465 | 0.75 | SMN1; SMN2 (0.37) | NPC1TP53HPGDNFKB1RAB9A | |
| SCHEMBL12637468 | 0.74 | SMN1; SMN2 (0.47) | NPC1TP53HPGDNFKB1RAB9A | |
| SCHEMBL12637467 | 0.73 | SMN1; SMN2 (0.43) | NPC1TP53HPGDNFKB1RAB9A | |
| SCHEMBL12637464 | 0.71 | ENPP1 (0.42) | NPC1TP53HPGDNFKB1RAB9A | |
| SCHEMBL12637481 | 0.71 | SMN1; SMN2 (0.45) | NPC1TP53HPGDNFKB1RAB9A | |
| SCHEMBL12637496 | 0.71 | NAMPT (0.33) | ALDH1A1 | |
| SCHEMBL12637466 | 0.69 | ENPP1 (0.44) | NPC1TP53HPGDNFKB1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7939669-B2 | Metallic compound and organic electroluminescence device comprising the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-05-10 | — | — | US | disclosed |
| US-20090306395-A1 | METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306395-A1 | METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | SCO2, RPS4Y1, RER1 | NPC1 2314/4885TP53 3658/4885HPGD 3538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.